Is long-term medication required after taking Daprodustat?

Daprodustat is convenient to take orally, but whether its use requires long-term maintenance mainly depends on the progression of chronic kidney disease. Chronic kidney disease is a progressive disease, and declining renal function will continue to affect endogenous erythropoietin secretion, so many patients require long-term treatment with daprostat to maintain hemoglobin within a safe and target range. Stopping medication may cause hemoglobin to drop, and symptoms of anemia such as fatigue, palpitations, decreased concentration, and reduced immunity may reappear.

Clinical practice shows that long-term use of dapostat can stabilize hemoglobin and reduce the frequency of erythropoietin injections, thereby reducing patient compliance barriers and treatment burden. Patients should regularly monitor hemoglobin, blood pressure and iron metabolism indicators during use to ensure that hemoglobin rises at an appropriate rate and reduces the risk of cardiovascular events. For dialysis patients, daprostat can also improve the convenience of blood management and improve the quality of daily life.

In addition, patients need to pay attention to lifestyle management during long-term medication, including a balanced diet, reasonable iron supplementation, moderate exercise, and maintaining cardiovascular health. The doctor will adjust the dose according to the patient's changes in renal function, hemoglobin fluctuations and complications to achieve an individualized medication plan. Overseas clinical guidelines recommend that maintaining hemoglobin within the recommended range and closely following cardiovascular indicators and iron metabolism status can reduce potential risks.

In short, dapoprimostat is becoming an important innovative drug in the management of anemia in chronic kidney disease due to its advantages of oral convenience, stable hemoglobin and controllable safety. Daprostat usually requires long-term maintenance use, but through standardized monitoring, individualized dose adjustment and lifestyle intervention, patients can achieve sustained and stable hemoglobin improvement while reducing the risks associated with long-term medication, providing a reliable oral treatment option for anemia in chronic kidney disease.

Reference materials:https://en.wikipedia.org/wiki/Daprodustat